Radiation vs. chemotherapy: new lung cancer treatment showdown before surgery
NCT ID NCT05798845
Summary
This study is testing whether combining an immunotherapy drug (toripalimab) with targeted radiation works better than combining it with standard chemotherapy when given before surgery for certain stages of non-small cell lung cancer. The goal is to shrink tumors more effectively to make surgery more successful and reduce the chance of the cancer coming back. Researchers will compare the safety and effectiveness of these two different pre-surgery approaches in 124 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, 200030, China
Contact
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.